Indaptus Therapeutics, Inc. (INDP) Form SCHEDULE 13D/A — Oct 22, 2026
Sino Lion Ventures Limited and Chenhao Xu filed Amendment No. 3 to their Schedule 13D on Indaptus Therapeutics, reporting beneficial ownership of 38,895,000 common shares, or 25.325% of the class, with shared voting and dispositive power. The amendment was required because the stake fell by more than 1% due solely to Indaptus issuing 20,338,974 new shares in a private placement that closed October 16, 2026; the Reporting Persons bought or sold nothing.
Key figures
- Shares Outstanding
- 153581298
- Percent Owned
- 25.325%
- Funds Used For Purchase
- $3,998,898.44
- Shares Beneficially Owned
- 38895000
- Private Placement Shares Issued
- 20338974
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.